TCG NEWS
The Column Group Raises Over $400 Million For Its New Fund, TCG Labs-Soleil
February 1, 2024
The Column Group launches a novel ‘venture-biotech’ model, creating an integrated ecosystem to exclusively fund, discover, and develop single-asset biologic therapies.
Dr. Dan Nomura joins The Column Group as iPartner
July 1, 2023
The Column Group announced the recruitment of Dr. Dan Nomura to the firm’s renowned group of iPartners. Dr. Nomura is a Professor of Chemical Biology
The Column Group Raises $1.23 Billion in Two New Funds
June 9, 2022
We are very excited to announce that we have closed the two newest funds of the TCG fund family – The Column Group V (“TCG
Dr. Hui Tian joins The Column Group as Venture Partner
May 1, 2022
The Column Group announces the hiring of Dr. Hui Tian. Previously, Dr. Tian was a founding member of NGM Biopharmaceuticals and most recently served as
